Preprint · CC-BY
via OpenAlex
Multiparametric senescent cell phenotyping reveals CD24 osteolineage cells as targets of senolytic therapy in the aged murine skeleton
Madison L. Doolittle, Dominik Saul, Japneet Kaur, Jennifer L. Rowsey, Stephanie J. Vos, Kevin D. Pavelko, Joshua N. Farr, David G. Monroe, Sundeep Khosla
bioRxiv (Cold Spring Harbor Laboratory) · 2023 · ▲ 2 citations
Genomic instability
Cellular senescence
Chronic inflammation
Senolytics
Cell culture / in vitro
Mouse
In vitro
Abstract
ABSTRACT Senescence(definition) drives organismal aging, yet the deep characterization of senescent cells in vivo remains incomplete. Here, we applied mass cytometry by time-of-flight (CyTOF) using carefully validated antibodies to analyze senescent cells at single-cell resolution. We used multiple criteria to identify senescent mesenchymal cells that were growth arrested and resistant to apoptosis (p16+/Ki67-/BCL-2+; “p16KB” cells). These cells were highly enriched for senescence-associated secretory phenotype (SASP) and DNA damage markers and were strongly associated with age. p16KB cell percentages were also increased in CD24+ osteolineage cells, which exhibited an inflammatory SASP in aged mice and were robustly cleared by both genetic and pharmacologic senolytic therapies. Following isolation, CD24+ skeletal cells exhibited growth arrest, SA-βgal positivity, and impaired osteogenesis in vitro . These studies thus provide a new approach using multiplexed protein profiling by CyTOF to define senescent mesenchymal cells in vivo and identify a highly inflammatory, senescent CD24+ osteolineage population cleared by senolytics(definition).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2023.01.12.523760
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Doolittle, M.L., Saul, D., Kaur, J., Rowsey, J.L., Vos, S.J., Pavelko, K.D., Farr, J.N., Monroe, D.G., & Khosla, S. (2023). Multiparametric senescent cell phenotyping reveals CD24 osteolineage cells as targets of senolytic therapy in the aged murine skeleton. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/2023.01.12.523760
Vancouver
Doolittle ML, Saul D, Kaur J, Rowsey JL, Vos SJ, Pavelko KD, et al. Multiparametric senescent cell phenotyping reveals CD24 osteolineage cells as targets of senolytic therapy in the aged murine skeleton. bioRxiv (Cold Spring Harbor Laboratory). 2023. doi:10.1101/2023.01.12.523760.
BibTeX
@unpublished{madison2023Multip,
title = {Multiparametric senescent cell phenotyping reveals CD24 osteolineage cells as targets of senolytic therapy in the aged murine skeleton},
author = {Madison L. Doolittle and Dominik Saul and Japneet Kaur and Jennifer L. Rowsey and Stephanie J. Vos and Kevin D. Pavelko and Joshua N. Farr and David G. Monroe and Sundeep Khosla},
journal = {bioRxiv (Cold Spring Harbor Laboratory)},
year = {2023},
doi = {10.1101/2023.01.12.523760},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Communications 2023
Open access · CC-BY
Multiparametric senescent cell phenotyping reveals targets of senolytic therapy in the aged murine skeleton
Cell 2026
Citation only
Mesenchymal drift: A convergent framework for the hallmarks of aging.
Aging Cell 2025
Open access · CC-BY
Senolytic‐Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers
Nature Communications 2022
Open access · CC-BY
A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues
EBioMedicine 2019
Open access · CC-BY
Senolytics and senostatics as adjuvant tumour therapy
medRxiv 2024
Preprint · OA